A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also found that patients with cancer are more likely to use prescription opioids than adults without cancer. Pain is […]
Medical Marijuana
Legal Marijuana Could Be Next Big Opportunity in Health Care
While cannabis isn’t yet legal across the U.S., new technologies are already opening doors to promising new applications of marijuana—and pharmaceutical companies are gearing up for a future where these options could hit the market, says Piper Jaffray. The back story. In 2017 Canada legalized cannabis, but the road toward acceptance in the U.S. looks longer. The U.S. has taken […]
Promoting MMJ Among Cancer Patients in the USA
John Taenzler, Ph.D. In October 2018, a survey was conducted among 92 patients currently being treated for cancer in 17 of the States where medical marijuana (MMJ) has been approved and available. An objective of this research was to assess the depth of knowledge about cannabis claims, logistics for acquiring/using MMJ, and attitudes of their […]
Fresh guidance to fill ‘information vacuum’ on new cannabis products for medicinal use
A clinical review, published today (Saturday 6 April 2019) for the BMJ, provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions. Since a policy change in November 2018, specialist doctors registered with the General Medical Council (GMC), have been permitted to prescribe new medicines which derive […]
Is the Endocannabinoid System the Key to Happiness?
Have you ever heard the saying, “happy wife, happy life?” What makes that wife happy? Is it the peacefulness of her family? A stable job? A loving partner? Or, a healthy endocannabinoid system? Could a well-functioning endocannabinoid system (ECS) be the key to our level of happiness? We have heard stories about endocannabinoid deficiency syndrome, but what, if anything, is the proof […]
Promoting MMJ Among Oncologist in the USA
By John Taenzler, Ph.D. In October 2018, a survey was conducted among 87 oncologists (ONCs) in 19 of the States where medical marijuana (MMJ) has been approved and available. An objective of this research was to assess the depth of knowledge about cannabis pharmacology, state-specific regulations, and attitudes of national medical organizations toward MMJ. In […]
Nexien BioPharma to File Pre-IND Meeting Request with the FDA
PRESS RELEASE Encouraging clinical observations and patient questionnaire results indicate that specific cannabinoid formulations are supportive in the treatment of patients suffering from myotonic dystrophy DENVER–(BUSINESS WIRE)–Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development and commercialization of novel FDA-compliant cannabinoid pharmaceuticals and related drug delivery […]
Cannabis Real Estate Evolution: What you need to consider
By Jacques Santucci The cannabis industry is evolving rapidly and so is your view of the real-estate market From coast to coast, America’s real estate markets are facing considerable shifts due to the advent of the legal cannabis industry, prompting once derelict store fronts and industrial warehouses to skyrocket in price, with competition for precious […]
Advances in MMJ: MJBizCon Las Vegas 2018
Congratulation to MJBiz for a successful conference in Las Vegas. The turn-out was astounding. In the Key Note address, Torsten Keunzlen from SunDial, perfectly captured this time in the growth of MMJ as a legitimate treatment for a host of medical conditions. Paraphrasing, Mr. Keunzlen stated: The Cannabis Industry is at a turning-point, and we in […]
Big Pharma is Coming for the Cannabis Industry
In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or the side effects of their therapy. Furthermore, among those physicians who have never recommended MMJ […]
Perceptions of MMJ Among Pain Specialists in The USA
By John Taenzler, Ph.D., Partner The following data was drawn from a survey of 86 Pain Management Specialists (APMs) in states where MMJ is legal. All data was collected using a double-blind protocol. Cannalytic Insights adheres to the CASRO Code of Standards and Ethics. When asked about their history of recommending MMJ to their pain […]
